Defense World
25 Dec 2025, 08:20 UTC · 37w ago
Verdict
Headline takes no side. We score CRBP +0.30 across two claims — moderately bullish.
+0.30moderately bullish
More positive than 60% of ticker scores this week
What the story claims
2 claims · scored −1 bearish … +1 bullish
Assenagon Asset Management S.A. established a new position in Corbus Pharmaceuticals (CRBP) in Q3.
More positive than 55% of claims this week
The new investment consists of 85,347 shares valued at approximately $1,080,000.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
More positive than 47% of claims this week
Which stocks this story touches
More positive than 60% of ticker scores this week
An institutional investor established a new position in the company, indicating positive sentiment and confidence.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Globe News Wire
5h ago
−4.2%
Price is moving against the score
$8.08 vs $8.43 close before publication (Dec 24) · not market-adjusted
CRBP chart →
